EI
GSK icon

Ellevest Inc’s GSK GSK Stock Holding History

Ellevest Inc’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$872K Sell
16,672
-745
-4% -$39.4K 0.1% 138
2026
Q1 		$961K Sell
17,417
-754
-4% -$40.9K 0.13% 104
2025
Q4 		$891K Sell
18,171
-1,210
-6% -$56.4K 0.12% 117
2025
Q3 		$836K Buy
19,381
+180
+0.9% +$7.03K 0.12% 122
2025
Q2 		$737K Sell
19,201
-1,737
-8% -$66.4K 0.12% 128
2025
Q1 		$811K Buy
20,938
+7,140
+52% +$261K 0.05% 123
2024
Q4 		$467K Sell
13,798
-5,301
-28% -$191K 0.03% 210
2024
Q3 		$781K Buy
19,099
+1,137
+6% +$46.5K 0.04% 141
2024
Q2 		$692K Buy
17,962
+3,616
+25% +$152K 0.04% 151
2024
Q1 		$615K Sell
14,346
-1,211
-8% -$49.9K 0.04% 160
2023
Q4 		$577K Buy
15,557
+1,535
+11% +$55.1K 0.04% 158
2023
Q3 		$508K Sell
14,022
-1,190
-8% -$42.2K 0.04% 143
2023
Q2 		$542K Sell
15,212
-523
-3% -$18.8K 0.04% 140
2023
Q1 		$560K Buy
15,735
+3,204
+26% +$112K 0.04% 115
2022
Q4 		$440K Buy
12,531
+3,443
+38% +$115K 0.04% 146
2022
Q3 		$267K Sell
9,088
-3,576
-28% -$136K 0.03% 214
2022
Q2 		$689K Buy
12,664
+1,606
+15% +$88.7K 0.06% 72
2022
Q1 		$602K Buy
11,058
+1,704
+18% +$92.6K 0.05% 89
2021
Q4 		$516K Buy
9,354
+1,714
+22% +$89.2K 0.05% 100
2021
Q3 		$365K Buy
7,640
+5,822
+320% +$292K 0.04% 148
2021
Q2 		$91K Buy
1,818
+766
+73% +$36.8K 0.01% 381
2021
Q1 		$47K Sell
1,052
-3,342
-76% -$152K 0.01% 490
2020
Q4 		$202K Sell
4,394
-4,485
-51% -$206K 0.03% 166
2020
Q3 		$418K Buy
8,879
+391
+5% +$19.6K 0.08% 71
2020
Q2 		$433K Buy
8,488
+793
+10% +$40.7K 0.09% 53
2020
Q1 		$364K Buy
7,695
+6,811
+770% +$363K 0.1% 47
2019
Q4 		$52K Buy
884
+737
+501% +$41K 0.01% 184
2019
Q3 		$8K Sell
147
-198
-57% -$10.2K ﹤0.01% 238
2019
Q2 		$17K Buy
+345
New +$17.3K 0.01% 211

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Ellevest Inc's GSK Position: Q2 2026 in Review

Ellevest Inc reduced its GSK (GSK) stake by 4.3% in Q2 2026, selling an estimated $39.4K and leaving 16,672 shares worth $872K. The position accounts for 0.1% of the portfolio, ranked #138.

Ellevest Inc first reported a position in GSK in Q2 2019 and has held it in 29 quarters since. The position peaked at $961K in Q1 2026. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Ellevest Inc held 16,672 shares of GSK worth $872K as of Q2 2026.
  • Ellevest Inc sold 745 GSK shares in Q2 2026, an estimated $39.4K.
  • GSK made up 0.1% of Ellevest Inc's portfolio in Q2 2026, its #138 holding.
  • Ellevest Inc first reported a position in GSK in Q2 2019 and has held it in 29 quarters since.
  • Ellevest Inc's GSK position peaked at $961K in Q1 2026.
  • 1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Ellevest Inc's 13F filing for Q2 2026, filed 10 Aug 2026.